ID26650A - Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik - Google Patents
Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginikInfo
- Publication number
- ID26650A ID26650A IDW20002368A ID20002368A ID26650A ID 26650 A ID26650 A ID 26650A ID W20002368 A IDW20002368 A ID W20002368A ID 20002368 A ID20002368 A ID 20002368A ID 26650 A ID26650 A ID 26650A
- Authority
- ID
- Indonesia
- Prior art keywords
- alginic acid
- levosimendants
- compositions containing
- stable compositions
- levosimendan
- Prior art date
Links
- 229960001126 alginic acid Drugs 0.000 title abstract 2
- 235000010443 alginic acid Nutrition 0.000 title abstract 2
- 229920000615 alginic acid Polymers 0.000 title abstract 2
- 239000000783 alginic acid Substances 0.000 title abstract 2
- 150000004781 alginic acids Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- WHXMKTBCFHIYNQ-SECBINFHSA-N levosimendan Chemical compound C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1 WHXMKTBCFHIYNQ-SECBINFHSA-N 0.000 abstract 3
- 229960000692 levosimendan Drugs 0.000 abstract 3
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Jellies, Jams, And Syrups (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI980902A FI980902A7 (fi) | 1998-04-23 | 1998-04-23 | Levosimendaanin stabiileja koostumuksia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26650A true ID26650A (id) | 2001-01-25 |
Family
ID=8551576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002368A ID26650A (id) | 1998-04-23 | 1999-04-23 | Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6531458B1 (cs) |
| EP (1) | EP1079834B1 (cs) |
| JP (1) | JP4475809B2 (cs) |
| KR (1) | KR100590622B1 (cs) |
| CN (1) | CN1165309C (cs) |
| AT (1) | ATE231395T1 (cs) |
| AU (1) | AU756338B2 (cs) |
| BG (1) | BG64766B1 (cs) |
| BR (1) | BR9909867A (cs) |
| CA (1) | CA2329232C (cs) |
| CZ (1) | CZ290911B6 (cs) |
| DE (1) | DE69905034T2 (cs) |
| DK (1) | DK1079834T3 (cs) |
| EA (1) | EA002428B1 (cs) |
| EE (1) | EE04143B1 (cs) |
| ES (1) | ES2191426T3 (cs) |
| FI (1) | FI980902A7 (cs) |
| GE (1) | GEP20032942B (cs) |
| HR (1) | HRP20000703B1 (cs) |
| HU (1) | HUP0105446A3 (cs) |
| ID (1) | ID26650A (cs) |
| IL (2) | IL138950A0 (cs) |
| MX (1) | MXPA00010368A (cs) |
| NO (1) | NO318575B1 (cs) |
| NZ (1) | NZ507455A (cs) |
| PL (1) | PL192274B1 (cs) |
| PT (1) | PT1079834E (cs) |
| RS (1) | RS49955B (cs) |
| SK (1) | SK284600B6 (cs) |
| TR (1) | TR200003101T2 (cs) |
| WO (1) | WO1999055337A1 (cs) |
| ZA (1) | ZA200005630B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI980901A7 (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
| FI109659B (fi) * | 1999-09-10 | 2002-09-30 | Orion Yhtymae Oyj | Levosimendaanin farmaseuttisia liuoksia |
| FI20010233A0 (fi) * | 2001-02-08 | 2001-02-08 | Orion Corp | Menetelmä sydämen vajaatoiminnan hoitoon |
| WO2002064120A1 (fr) * | 2001-02-13 | 2002-08-22 | Taisho Pharmaceutical Co., Ltd. | Preparations de gel a usage interne |
| JP2008533109A (ja) * | 2005-03-14 | 2008-08-21 | オリオン コーポレーション | 利尿を促進するための複合治療 |
| CN108289832B (zh) * | 2015-11-06 | 2021-08-31 | 卡利努法姆股份有限公司 | 用于以输注或注射形式进行静脉给药的左西孟旦以及输注浓缩液的改善配方 |
| WO2021126884A1 (en) | 2019-12-16 | 2021-06-24 | Tenax Therapeutics, Inc. | LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HF-pEF) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1509866A (en) | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| AU555304B2 (en) * | 1982-04-05 | 1986-09-18 | Merck Sharp & Dohme Limited | Stabilization of drugs in alginic acid and magnesium hydroxide granules |
| EP0123291A2 (en) | 1983-04-20 | 1984-10-31 | Kyowa Hakko Kogyo Co., Ltd. | Method for stabilizing interferon |
| US4906630A (en) * | 1985-11-22 | 1990-03-06 | Rorer Pharmaceutical Corporation | Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds |
| US4716042A (en) | 1986-06-16 | 1987-12-29 | American Home Products Corporation | Stabilized coated aspirin tablets |
| GB8903130D0 (en) | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
| GB2251615B (en) | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
| GB2266841A (en) | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
| GB9614098D0 (en) | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
| FI973804A7 (fi) * | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
-
1998
- 1998-04-23 FI FI980902A patent/FI980902A7/fi unknown
-
1999
- 1999-04-23 KR KR1020007011789A patent/KR100590622B1/ko not_active Expired - Fee Related
- 1999-04-23 MX MXPA00010368A patent/MXPA00010368A/es active IP Right Grant
- 1999-04-23 PT PT99916943T patent/PT1079834E/pt unknown
- 1999-04-23 SK SK1555-2000A patent/SK284600B6/sk not_active IP Right Cessation
- 1999-04-23 US US09/673,793 patent/US6531458B1/en not_active Expired - Fee Related
- 1999-04-23 PL PL343722A patent/PL192274B1/pl not_active IP Right Cessation
- 1999-04-23 EA EA200001097A patent/EA002428B1/ru not_active IP Right Cessation
- 1999-04-23 ID IDW20002368A patent/ID26650A/id unknown
- 1999-04-23 ES ES99916943T patent/ES2191426T3/es not_active Expired - Lifetime
- 1999-04-23 NZ NZ507455A patent/NZ507455A/en unknown
- 1999-04-23 RS YUP-640/00A patent/RS49955B/sr unknown
- 1999-04-23 GE GEAP19995638A patent/GEP20032942B/en unknown
- 1999-04-23 DK DK99916943T patent/DK1079834T3/da active
- 1999-04-23 JP JP2000545535A patent/JP4475809B2/ja not_active Expired - Lifetime
- 1999-04-23 HR HR20000703A patent/HRP20000703B1/xx not_active IP Right Cessation
- 1999-04-23 EP EP99916943A patent/EP1079834B1/en not_active Expired - Lifetime
- 1999-04-23 IL IL13895099A patent/IL138950A0/xx active IP Right Grant
- 1999-04-23 TR TR2000/03101T patent/TR200003101T2/xx unknown
- 1999-04-23 DE DE69905034T patent/DE69905034T2/de not_active Expired - Lifetime
- 1999-04-23 WO PCT/FI1999/000331 patent/WO1999055337A1/en active IP Right Grant
- 1999-04-23 CA CA002329232A patent/CA2329232C/en not_active Expired - Fee Related
- 1999-04-23 CN CNB998053805A patent/CN1165309C/zh not_active Expired - Fee Related
- 1999-04-23 AT AT99916943T patent/ATE231395T1/de not_active IP Right Cessation
- 1999-04-23 BR BR9909867-9A patent/BR9909867A/pt not_active Application Discontinuation
- 1999-04-23 EE EEP200000616A patent/EE04143B1/xx not_active IP Right Cessation
- 1999-04-23 CZ CZ20003779A patent/CZ290911B6/cs not_active IP Right Cessation
- 1999-04-23 HU HU0105446A patent/HUP0105446A3/hu unknown
- 1999-04-23 AU AU35248/99A patent/AU756338B2/en not_active Ceased
-
2000
- 2000-10-11 IL IL138950A patent/IL138950A/en not_active IP Right Cessation
- 2000-10-12 ZA ZA200005630A patent/ZA200005630B/en unknown
- 2000-10-20 NO NO20005312A patent/NO318575B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104958A patent/BG64766B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2714830B1 (fr) | Composition contenant des acides nucléiques, préparation et utilisations. | |
| ATE289332T1 (de) | Silikongel enthaltend salizylsäure | |
| BR9810450A (pt) | Derivados de ácido barbitúrico com atividade antimetastática e antitumor | |
| BRPI9917007B8 (pt) | azabicicloalcanos como moduladores de ccr5, composição farmacêutica contendo os mesmos, bem como seu uso | |
| ATE292460T1 (de) | Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels | |
| PT799209E (pt) | Novas sulfonamidas | |
| BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
| IL129068A0 (en) | Sulfinic acid derivatives and their preparation and use | |
| CA2224528A1 (fr) | Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations | |
| AU2001283353A1 (en) | Compositions containing hypoglycemically active stilbenoids | |
| CA2238465A1 (fr) | Composes triaromatiques, compositions les contenant et utilisations | |
| FR2826270B1 (fr) | Lingette et ses utilisations dans le domaine cosmetique | |
| DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
| ATE297188T1 (de) | Stabilisierte ascorbinsäure-lösungen | |
| NO20061138L (no) | Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi | |
| YU16902A (sh) | Farmaceutski rastvori levosimendana | |
| GB9928820D0 (en) | Stable high glycerol liquids comprising sulfosuccinic acid monoesters | |
| ID26650A (id) | Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik | |
| DK1051159T3 (da) | Faste farmaceutiske præparater indeholdende miltefosin til oral administration ved behandling af leishmaniasis | |
| HUP9801593A2 (hu) | Benazeprilt vagy benazeprilátot és valzartánt tartalmazó kombinált gyógyszerkészítmények és azok alkalmazása | |
| DE60230155D1 (de) | Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung | |
| CA2291650A1 (fr) | Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant | |
| ATE90354T1 (de) | Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden. | |
| YU17999A (sh) | Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu | |
| DE60225530D1 (de) | Phosphorylierte glyoxalase i und deren verwendung |